Skip to main content
. 2018 Sep 28;10(2):148–152. doi: 10.1007/s13340-018-0376-9

Fig. 1.

Fig. 1

Effect of linagliptin on oxidative stress and inflammation markers after 3 months of treatment: a MDA-LDL (mg/dl), b urinary 8-OHdG excretion (ng/gCr), and c high-sensitive CRP ng/ml levels at baseline (0 M) and after 3 months of treatment (3 M). Data express mean ± SD